Loading clinical trials...
Loading clinical trials...
A Blind Randomized Multicenter Study of Accelerated Fractionated Chemo-radiotherapy With or Without the Hypoxic Cell Radiosensitizer Nimorazole (Nimoral), Using a 15-gene Signature for Hypoxia in the Treatment of Squamous Cell Carcinoma of the Head and Neck.
Conditions
Interventions
Cisplatin
Radiotherapy
+2 more
Locations
19
Australia
Royal Brisbane And Women's Hospital
Brisbane, Australia
Princess Alexandra Hospital - University Of Queensland
Brisbane, Australia
Royal North Shore Hospital
St Leonards, Australia
Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet
Brussels, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium
Start Date
July 25, 2014
Primary Completion Date
September 6, 2019
Completion Date
January 9, 2023
Last Updated
May 10, 2022
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions